Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Enzynomics is a South Korean biotechnology company specializing in the development and manufacture of high-purity enzymes for molecular biology research and diagnostic applications. Founded in 2007, the company provides a comprehensive portfolio of products including DNA polymerases, restriction enzymes, ligases, and kits for Next-Generation Sequencing (NGS) library preparation. Enzynomics leverages its proprietary protein expression and purification technologies to supply critical reagents to academic, clinical, and industrial laboratories worldwide. The company also offers custom enzyme development services and contract manufacturing for diagnostic kit components. Its products are widely used in PCR, cloning, and genomic analysis workflows.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Enzynomics.